Loading...
Loading...
Among the 9 tracked institutional investors we monitor, ARWR (ARROWHEAD PHARMACEUTICALS IN) is held with a combined value of $3.24B across 50,739,146 shares. The largest holder is BlackRock, Inc. with a position worth $1.14B (0.02% of their portfolio). 2 funds opened new positions in the most recent quarter. 4 funds increased their holdings. 3 funds reduced their position.
Total Institutional Value
$3.24B
Total Shares Held
50,739,146
Institutional Holders
9
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $1.14B | 0.02% | -14.8% |
| 2 | VANGUARD GROUP INC | $1.02B | 0.01% | New |
| 3 | FMR LLC | $455.62M | 0.02% | +11.4% |
| 4 | STATE STREET CORP | $407.31M | 0.01% | +1.4% |
| 5 | BAKER BROS. ADVISORS LP | $124.95M | 0.72% | -8.4% |
| 6 | RENAISSANCE TECHNOLOGIES LLC | $64.99M | 0.10% | New |
| 7 | CITADEL ADVISORS LLC | $21.98M | 0.00% | -54.8% |
| 8 | Bridgewater Associates, LP | $5.99M | 0.03% | +59.3% |
| 9 | Point72 Asset Management, L.P. | $2.91M | 0.00% | +45.5% |
As of the latest SEC 13F filings, BlackRock, Inc. is the largest institutional holder of ARWR with a position worth $1.14B, representing 0.02% of their portfolio. In total, 9 institutional investors hold ARWR with a combined value of $3.24B.
In the most recent quarter, 2 funds opened a new position in ARWR. Additionally, 4 increased their holdings and 3 reduced their positions.
Institutional investors hold $3.24B worth of ARWR stock across 9 positions. The largest institutional holder is BlackRock, Inc. with $1.14B in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For ARWR, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their ARWR positions.